Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Jan;71(1):299–306. doi: 10.1128/jvi.71.1.299-306.1997

Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses.

J D Wetzel 1, J D Chappell 1, A B Fogo 1, T S Dermody 1
PMCID: PMC191051  PMID: 8985350

Abstract

To determine mechanisms by which persistent viral infections are established and maintained, we initiated persistent infections of murine erythroleukemia (MEL) cells by using reovirus strains type 3 Abney and type 3 Dearing. Establishment of persistent reovirus infections of MEL cells was not associated with a significant cytopathic effect despite the presence of high titers of infectious virus in the cultures (>10(5) PFU/ml of culture lysate). Maintenance of persistently infected MEL-cell cultures was associated with coevolution of mutant viruses and cells. Mutant viruses produced greater yields than the parental wild-type (wt) strains in MEL cells cured of persistent infection and in cells treated with ammonium chloride, a weak base that blocks viral disassembly. Mutant cells supported growth of wt infectious subvirion particles, which are disassembly intermediates generated in vitro by treatment of virions with chymotrypsin, substantially better than growth of wt virions. These findings indicate that viral and cellular mutations selected during maintenance of persistently infected MEL-cell cultures affect acid-dependent proteolysis of virions during entry into cells. We also found that wt infectious subvirion particles produce greater yields than wt virions in wt MEL cells, which suggests that inefficient viral disassembly in MEL cells favors establishment of persistent infection. Therefore, steps in reovirus replication leading to viral disassembly appear to be critical determinants of the capacity of MEL cells to support both establishment and maintenance of persistent reovirus infections.

Full Text

The Full Text of this article is available as a PDF (538.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed R., Canning W. M., Kauffman R. S., Sharpe A. H., Hallum J. V., Fields B. N. Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection. Cell. 1981 Aug;25(2):325–332. doi: 10.1016/0092-8674(81)90050-7. [DOI] [PubMed] [Google Scholar]
  2. Ahmed R., Chakraborty P. R., Graham A. F., Ramig R. F., Fields B. N. Genetic variation during persistent reovirus infection: presence of extragenically suppressed temperature-sensitive lesions in wild-type virus isolated from persistently infected L cells. J Virol. 1980 May;34(2):383–389. doi: 10.1128/jvi.34.2.383-389.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ahmed R., Fields B. N. Role of the S4 gene in the establishment of persistent reovirus infection in L cells. Cell. 1982 Mar;28(3):605–612. doi: 10.1016/0092-8674(82)90215-x. [DOI] [PubMed] [Google Scholar]
  4. Ahmed R., Graham A. F. Persistent infections in L cells with temperature-sensitive mutants of reovirus. J Virol. 1977 Aug;23(2):250–262. doi: 10.1128/jvi.23.2.250-262.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bassel-Duby R., Jayasuriya A., Chatterjee D., Sonenberg N., Maizel J. V., Jr, Fields B. N. Sequence of reovirus haemagglutinin predicts a coiled-coil structure. 1985 May 30-Jun 5Nature. 315(6018):421–423. doi: 10.1038/315421a0. [DOI] [PubMed] [Google Scholar]
  6. Borsa J., Sargent M. D., Lievaart P. A., Copps T. P. Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process. Virology. 1981 May;111(1):191–200. doi: 10.1016/0042-6822(81)90664-4. [DOI] [PubMed] [Google Scholar]
  7. Borzakian S., Couderc T., Barbier Y., Attal G., Pelletier I., Colbère-Garapin F. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology. 1992 Feb;186(2):398–408. doi: 10.1016/0042-6822(92)90005-a. [DOI] [PubMed] [Google Scholar]
  8. Burstin S. J., Spriggs D. R., Fields B. N. Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology. 1982 Feb;117(1):146–155. doi: 10.1016/0042-6822(82)90514-1. [DOI] [PubMed] [Google Scholar]
  9. Canning W. M., Fields B. N. Ammonium chloride prevents lytic growth of reovirus and helps to establish persistent infection in mouse L cells. Science. 1983 Feb 25;219(4587):987–988. doi: 10.1126/science.6297010. [DOI] [PubMed] [Google Scholar]
  10. Chang C. T., Zweerink H. J. Fate of parental reovirus in infected cell. Virology. 1971 Dec;46(3):544–555. doi: 10.1016/0042-6822(71)90058-4. [DOI] [PubMed] [Google Scholar]
  11. Chen W., Baric R. S. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J Virol. 1996 Jun;70(6):3947–3960. doi: 10.1128/jvi.70.6.3947-3960.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Danis C., Mabrouk T., Garzon S., Lemay G. Establishment of persistent reovirus infection in SC1 cells: absence of protein synthesis inhibition and increased level of double-stranded RNA-activated protein kinase. Virus Res. 1993 Mar;27(3):253–265. doi: 10.1016/0168-1702(93)90037-n. [DOI] [PubMed] [Google Scholar]
  13. Dermody T. S., Chappell J. D., Hofler J. G., Kramp W., Tyler K. L. Eradication of persistent reovirus infection from a B-cell hybridoma. Virology. 1995 Sep 10;212(1):272–276. doi: 10.1006/viro.1995.1483. [DOI] [PubMed] [Google Scholar]
  14. Dermody T. S., Nibert M. L., Wetzel J. D., Tong X., Fields B. N. Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. J Virol. 1993 Apr;67(4):2055–2063. doi: 10.1128/jvi.67.4.2055-2063.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Furlong D. B., Nibert M. L., Fields B. N. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol. 1988 Jan;62(1):246–256. doi: 10.1128/jvi.62.1.246-256.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kaplan G., Levy A., Racaniello V. R. Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle. J Virol. 1989 Jan;63(1):43–51. doi: 10.1128/jvi.63.1.43-51.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kowalik T. F., Yang Y. Y., Li J. K. Molecular cloning and comparative sequence analyses of bluetongue virus S1 segments by selective synthesis of specific full-length DNA copies of dsRNA genes. Virology. 1990 Aug;177(2):820–823. doi: 10.1016/0042-6822(90)90557-8. [DOI] [PubMed] [Google Scholar]
  18. Levy J. A., Henle G., Henle W., Zajac B. A. Effect of reovirus type 3 on cultured Burkitt's tumour cells. Nature. 1968 Nov 9;220(5167):607–608. doi: 10.1038/220607a0. [DOI] [PubMed] [Google Scholar]
  19. Lucia-Jandris P., Hooper J. W., Fields B. N. Reovirus M2 gene is associated with chromium release from mouse L cells. J Virol. 1993 Sep;67(9):5339–5345. doi: 10.1128/jvi.67.9.5339-5345.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mahy B. W. Strategies of virus persistence. Br Med Bull. 1985 Jan;41(1):50–55. doi: 10.1093/oxfordjournals.bmb.a072024. [DOI] [PubMed] [Google Scholar]
  21. Matsuzaki N., Hinshaw V. S., Fields B. N., Greene M. I. Cell receptors for the mammalian reovirus: reovirus-specific T-cell hybridomas can become persistently infected and undergo autoimmune stimulation. J Virol. 1986 Oct;60(1):259–266. doi: 10.1128/jvi.60.1.259-266.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Montgomery L. B., Kao C. Y., Verdin E., Cahill C., Maratos-Flier E. Infection of a polarized epithelial cell line with wild-type reovirus leads to virus persistence and altered cellular function. J Gen Virol. 1991 Dec;72(Pt 12):2939–2946. doi: 10.1099/0022-1317-72-12-2939. [DOI] [PubMed] [Google Scholar]
  23. Nibert M. L., Chappell J. D., Dermody T. S. Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved sigma 1 protein. J Virol. 1995 Aug;69(8):5057–5067. doi: 10.1128/jvi.69.8.5057-5067.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nibert M. L., Dermody T. S., Fields B. N. Structure of the reovirus cell-attachment protein: a model for the domain organization of sigma 1. J Virol. 1990 Jun;64(6):2976–2989. doi: 10.1128/jvi.64.6.2976-2989.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nibert M. L., Fields B. N. A carboxy-terminal fragment of protein mu 1/mu 1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. J Virol. 1992 Nov;66(11):6408–6418. doi: 10.1128/jvi.66.11.6408-6418.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nibert M. L., Furlong D. B., Fields B. N. Mechanisms of viral pathogenesis. Distinct forms of reoviruses and their roles during replication in cells and host. J Clin Invest. 1991 Sep;88(3):727–734. doi: 10.1172/JCI115369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ross J., Gielen J., Packman S., Ikawa Y., Leder P. Globin gene expression in cultured erythroleukemic cells. J Mol Biol. 1974 Aug 25;87(4):697–714. doi: 10.1016/0022-2836(74)90079-5. [DOI] [PubMed] [Google Scholar]
  28. Rubin D. H., Wetzel J. D., Williams W. V., Cohen J. A., Dworkin C., Dermody T. S. Binding of type 3 reovirus by a domain of the sigma 1 protein important for hemagglutination leads to infection of murine erythroleukemia cells. J Clin Invest. 1992 Dec;90(6):2536–2542. doi: 10.1172/JCI116147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Silverstein S. C., Astell C., Levin D. H., Schonberg M., Acs G. The mechanisms of reovirus uncoating and gene activation in vivo. Virology. 1972 Mar;47(3):797–806. doi: 10.1016/0042-6822(72)90571-5. [DOI] [PubMed] [Google Scholar]
  30. Sturzenbecker L. J., Nibert M., Furlong D., Fields B. N. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol. 1987 Aug;61(8):2351–2361. doi: 10.1128/jvi.61.8.2351-2361.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Taber R., Alexander V., Whitford W. Persistent reovirus infection of CHO cells resulting in virus resistance. J Virol. 1976 Feb;17(2):513–524. doi: 10.1128/jvi.17.2.513-524.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Verdin E. M., Maratos-Flier E., Carpentier J. L., Kahn C. R. Persistent infection with a nontransforming RNA virus leads to impaired growth factor receptors and response. J Cell Physiol. 1986 Sep;128(3):457–465. doi: 10.1002/jcp.1041280315. [DOI] [PubMed] [Google Scholar]
  33. Virgin H. W., 4th, Bassel-Duby R., Fields B. N., Tyler K. L. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol. 1988 Dec;62(12):4594–4604. doi: 10.1128/jvi.62.12.4594-4604.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Virgin H. W., 4th, Mann M. A., Tyler K. L. Protective antibodies inhibit reovirus internalization and uncoating by intracellular proteases. J Virol. 1994 Oct;68(10):6719–6729. doi: 10.1128/jvi.68.10.6719-6729.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES